Liver NF-kappaB and AP-1 DNA binding in obese patients (Q46150605)

19 December 2017

title

Liver NF-kappaB and AP-1 DNA binding in obese patients (English)

1 reference

19 December 2017

0 references

1 reference

Luis A Videla

1

1 reference

19 December 2017

Gladys Tapia

2

1 reference

19 December 2017

Ramón Rodrigo

3

1 reference

19 December 2017

Paulina Pettinelli

4

1 reference

19 December 2017

Daniela Haim

5

1 reference

19 December 2017

Catherine Santibañez

6

1 reference

19 December 2017

A Verónica Araya

7

1 reference

19 December 2017

Gladys Smok

8

1 reference

19 December 2017

Attila Csendes

9

1 reference

19 December 2017

Luis Gutierrez

10

1 reference

19 December 2017

Jorge Rojas

11

1 reference

19 December 2017

Jaime Castillo

12

1 reference

19 December 2017

Owen Korn

13

1 reference

19 December 2017

Fernando Maluenda

14

1 reference

19 December 2017

Juan C Díaz

15

1 reference

19 December 2017

Guillermo Rencoret

16

1 reference

19 December 2017

Jaime Poniachik

17

1 reference

19 December 2017

publication date

22 January 2009

1 reference

19 December 2017

published in

Obesity

1 reference

19 December 2017

volume

17

1 reference

19 December 2017

page(s)

973-979

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

Nonalcoholic fatty liver disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Splanchnic lipolysis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Toll-like receptor signaling in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

NF-kappaB activation by reactive oxygen species: fifteen years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

The molecular basis for oxidative stress-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Differential activation of transcription factors NF-kappa B and AP-1 in rat liver macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.601

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.601

1 reference

19 December 2017

PubMed ID

19165171

1 reference

19 December 2017